Abstract
Introduction Total hip replacement is the commonest arthroplasty procedure performed in the UK. The in-patient stay has gradually reduced and patients now typically spend five to seven days in hospital. We have developed a new multidisciplinary protocol for patients undergoing total hip replacement in order to facilitate early discharge.
The aims of this study were to prospectively assess whether this new protocol could be safely applied to patients undergoing total hip replacement and whether it reduced length of stay.
Methods The protocol involved a pre-operative program of education and physiotherapy, a modified anaesthetic regime, a minimally invasive surgical approach and a portable local anaesthetic pump infusion for post operative pain control. Strict inclusion and exclusion criteria were developed based on age, medical status and social circumstances. Patients were mobilised on the day of their operation and discharged to an outreach team support network. Independent evaluation was performed using the Oxford Hip Questionnaire, the Merle dAubigne clinical rating system and Visual Analogue Pain Scores.
Results Twenty-five patients underwent total hip replacement using the new protocol. All patients were discharged home within 48 hours of surgery. There were two unplanned reattendances neither of which required readmission. The mean pain score on discharge was 3/10. The Oxford Hip Questionnaire and Merle dAubigne scores were comparable to patients who underwent surgery prior to the introduction of the new protocol.
Discussion Minimising in-patient stay for total hip replacement benefits the patient by reducing exposure to nosocomial infection and expediting the return to a normal environment for rehabilitation. It may also help to improve efficiency and alleviate pressure on an overburdened health service. This new protocol allows patients undergoing total hip replacement to be discharged within 48 hours of undergoing surgery without compromising safety or quality of care.
Theses abstracts were prepared by Professor Roger Lemaire. Correspondence should be addressed to EFORT Central Office, Freihofstrasse 22, CH-8700 Küsnacht, Switzerland.
